{"id":3671,"date":"2024-05-11T19:21:33","date_gmt":"2024-05-11T17:21:33","guid":{"rendered":"https:\/\/rand-biotech.com\/?page_id=3671"},"modified":"2024-05-21T21:46:58","modified_gmt":"2024-05-21T19:46:58","slug":"company-profile-ita","status":"publish","type":"page","link":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/","title":{"rendered":"Company Profile &#8211; About &#8211; ITA"},"content":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_size=&#8221;h1&#8243; text_weight=&#8221;300&#8243;]<\/p>\n<h1>RAND &#8211; INNOVATION IN MEDICAL TECHNOLOGY<\/h1>\n<p>[\/vc_custom_heading][vc_separator sep_color=&#8221;color-wvjs&#8221; el_width=&#8221;200px&#8221; el_height=&#8221;2px&#8221;][vc_column_text]Fondata nel 1999 a Mirandola, rinomato distretto internazionale biomedicale, RanD \u00e8 una societ\u00e0 basata sul know-how acquisito dai soci fondatori in pi\u00f9 di 30 anni di esperienza nel settore.<\/p>\n<p>Il nome RanD deriva dalla trascrizione fonetica dell\u2019acronimo inglese R&amp;D (ricerca e sviluppo), espressione diretta dell&#8217;attivit\u00e0 principale di RanD: lo <strong>sviluppo di sistemi tecnologicamente innovativi basati su tecnologie di circolazione extracorporea,<\/strong> caratterizzati, allo stesso tempo, da una gestione operativa estremamente semplificata.<\/p>\n<p>Nel corso degli anni RanD ha sviluppato una serie di prodotti principalmente dedicati alla <strong>chirurgia oncologica<\/strong>, ma ha anche sfruttato il proprio know-how nello sviluppo di progetti innovativi per <strong>supporto epatico, supporto cardiopolmonare e dialisi.<\/strong><\/p>\n<p><strong>RanD gestisce direttamente l&#8217;intero ciclo di produzione di apparecchiature e dispositivi monouso<\/strong>, garantendo cos\u00ec elevati standard qualitativi per ogni fase di fabbricazione.<br \/>\nI prodotti RanD sono distribuiti in tutto il mondo direttamente o attraverso una rete di distribuzione capillare e in costante espansione, grazie alla quale pu\u00f2 fornire al cliente un servizio di post-vendita tempestivo e altamente professionale.<\/p>\n<p>Nel corso degli anni RanD ha stabilito una stretta collaborazione con medici di fama internazionale che hanno contribuito in modo essenziale allo sviluppo dei prodotti dell\u2019azienda. RanD \u00e8 in stretta collaborazione con i comitati di organizzazione di congressi ed eventi scientifici internazionali e svolge inoltre una costante attivit\u00e0 di formazione rivolta a medici e tecnici del settore.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_weight=&#8221;300&#8243; text_color=&#8221;color-163594&#8243;]Mission[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; back_color=&#8221;color-692600&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/1&#8243;][vc_custom_heading text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]Fornire ai pazienti prodotti di alta tecnologia che contribuiscano in modo significativo al miglioramento della loro salute.[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_weight=&#8221;300&#8243; text_color=&#8221;color-163594&#8243;][\/vc_custom_heading][vc_custom_heading text_size=&#8221;h1&#8243; text_weight=&#8221;300&#8243; text_color=&#8221;color-163594&#8243;]Tappe fondamentali[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-gyho&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;1193&#8243; media_width_percent=&#8221;100&#8243;][vc_custom_heading text_weight=&#8221;400&#8243;]1999[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243; text_color=&#8221;color-jevc&#8221;]<strong>Costituzione di RanD<\/strong>[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-692600&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;400&#8243; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;932&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][vc_custom_heading text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]2001[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]<span style=\"color: #ffffff;\"><strong>Performer LRT<\/strong><\/span><br \/>\n<span style=\"color: #ffffff;\">Il primo sistema multifunzionale per terapie di circolazione extracorporea: CRRT, plasmaferesi, supporto epatico artificiale e bioartificiale, chirurgica oncologica.<\/span>[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-gyho&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;600&#8243; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;1191&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][vc_custom_heading text_weight=&#8221;400&#8243;]2005[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243;]<strong>Performer CPB<\/strong><\/p>\n<p>La prima macchina cuore-polmone a sviluppo verticale.<br \/>\nIngombro pari ad un terzo dei sistemi tradizionali.<\/p>\n<p>Sviluppata per Medtronic Inc.<\/p>\n<p>[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-692600&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;800&#8243; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;430&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][vc_custom_heading text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]2008[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221; el_class=&#8221;link_bianco&#8221;]<strong>Performer HT<\/strong><br \/>\nIl sistema pi\u00f9 avanzato per la <a href=\"http:\/\/rand-biotech.com\/it\/extra-us-it\/performer-ht-hyperthermic-perfusion-treatments-in-surgical-oncology-hyperthermia-it\/\">Perfusione Ipertermica<\/a> nel settore della chirurgia oncologica[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-gyho&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;1000&#8243; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;1197&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][vc_custom_heading text_weight=&#8221;400&#8243;]2012[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243;]<strong>RanD USA<br \/>\n<\/strong>Approvazione del sistema Performer HT da parte dell\u2019FDA e costituzione di RanD USA con sede a Miami (FL)[\/vc_custom_heading][\/vc_column][vc_column column_width_percent=&#8221;100&#8243; back_color=&#8221;color-692600&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; medium_width=&#8221;0&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;1200&#8243; width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;1200&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221;][vc_custom_heading text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]2016[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h5&#8243; text_size=&#8221;h5&#8243; text_weight=&#8221;400&#8243; text_color=&#8221;color-xsdn&#8221;]<span style=\"color: #ffffff;\"><strong>Rigenerand<\/strong><\/span><br \/>\n<span style=\"color: #ffffff;\">Societ\u00e0 spin-off nel campo della medicina rigenerativa<\/span>[\/vc_custom_heading][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_size=&#8221;h1&#8243; text_weight=&#8221;300&#8243;] RAND &#8211; INNOVATION IN MEDICAL TECHNOLOGY [\/vc_custom_heading][vc_separator sep_color=&#8221;color-wvjs&#8221; el_width=&#8221;200px&#8221; el_height=&#8221;2px&#8221;][vc_column_text]Fondata nel 1999 a Mirandola, rinomato [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":2340,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3671","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica<\/title>\n<meta name=\"description\" content=\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica\" \/>\n<meta property=\"og:description\" content=\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/\" \/>\n<meta property=\"og:site_name\" content=\"RAND\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-21T19:46:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\\\/company-profile-ita\\\/\",\"url\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\\\/company-profile-ita\\\/\",\"name\":\"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/#website\"},\"datePublished\":\"2024-05-11T17:21:33+00:00\",\"dateModified\":\"2024-05-21T19:46:58+00:00\",\"description\":\"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\\\/company-profile-ita\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rand-biotech.com\\\/it\\\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\\\/company-profile-ita\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\\\/company-profile-ita\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HOME &#8211; IT\",\"item\":\"https:\\\/\\\/rand-biotech.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Company Profile &#8211; About &#8211; ITA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rand-biotech.com\\\/#website\",\"url\":\"https:\\\/\\\/rand-biotech.com\\\/\",\"name\":\"RAND\",\"description\":\"Your Partner in Surgical Oncology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rand-biotech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/","og_locale":"it_IT","og_type":"article","og_title":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","og_description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","og_url":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/","og_site_name":"RAND","article_modified_time":"2024-05-21T19:46:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/","url":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/","name":"Tecnologie di circolazione extracorporea dedicati alla chirurgia oncologica","isPartOf":{"@id":"https:\/\/rand-biotech.com\/#website"},"datePublished":"2024-05-11T17:21:33+00:00","dateModified":"2024-05-21T19:46:58+00:00","description":"RanD sviluppa sistemi basati su tecnologie di circolazione extracorporea con prodotti principalmente dedicati alla chirurgia oncologica","breadcrumb":{"@id":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rand-biotech.com\/it\/rand-hipec-hithoc-ipertermia-carcinosi-perfusione\/company-profile-ita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rand-biotech.com\/it\/"},{"@type":"ListItem","position":2,"name":"HOME &#8211; IT","item":"https:\/\/rand-biotech.com\/it\/"},{"@type":"ListItem","position":3,"name":"Company Profile &#8211; About &#8211; ITA"}]},{"@type":"WebSite","@id":"https:\/\/rand-biotech.com\/#website","url":"https:\/\/rand-biotech.com\/","name":"RAND","description":"Your Partner in Surgical Oncology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rand-biotech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"_links":{"self":[{"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/pages\/3671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/comments?post=3671"}],"version-history":[{"count":2,"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/pages\/3671\/revisions"}],"predecessor-version":[{"id":3686,"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/pages\/3671\/revisions\/3686"}],"up":[{"embeddable":true,"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/pages\/2340"}],"wp:attachment":[{"href":"https:\/\/rand-biotech.com\/it\/wp-json\/wp\/v2\/media?parent=3671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}